Homepage arrow_right Deals & Advisory arrow_right Mergers & Acquisitions arrow_right Pfizer Acquires Array BioPharma

Pfizer Acquires Array BioPharma

Mergers & Acquisitions

Pfizer (NYSE: PFE), multinational pharmaceutical company, acquired Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on small molecule medicines, for $11.4 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.